| Venus Remedies Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 526953 |
NSE Symbol : VENUSREM |
P/E(TTM) : 17.64 |
|
ISIN Demat : INE411B01019 |
Div & Yield% : 0.00 |
EPS(TTM) : 46.67 |
|
Book Value(₹) : 467.25 |
Market Cap(₹Cr) : 1,100.24 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 192.65 | 137.13 | 194.04 | 172.54 | 169.67 | 105.86 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 192.65 | 137.13 | 194.04 | 172.54 | 169.67 | 105.86 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.68 | 2.72 | 6.77 | 11.65 | 8.06 | 1.56 |
| Total Income | 194.33 | 139.85 | 200.81 | 184.19 | 177.73 | 107.42 |
| Total Expenditure | 162.81 | 119.20 | 171.49 | 149.63 | 156.77 | 91.58 |
| PBIDT | 31.52 | 20.65 | 29.32 | 34.56 | 20.96 | 15.84 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 31.52 | 20.65 | 29.32 | 34.56 | 20.96 | 15.84 |
| Depreciation | 5.92 | 5.95 | 4.49 | 5.20 | 6.15 | 5.76 |
| Tax | 6.45 | 3.70 | 8.21 | 7.38 | 3.72 | 2.54 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.09 | -0.69 | 1.83 | -2.10 | 1.83 | 3.09 |
| Reported Profit After Tax | 19.24 | 11.69 | 14.79 | 24.08 | 9.26 | 4.45 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 7.42 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 19.24 | 11.69 | 14.79 | 16.66 | 9.26 | 4.45 |
| EPS (Unit Curr.) | 14.40 | 8.75 | 11.07 | 18.02 | 6.92 | 3.33 |
| EPS (Adj) (Unit Curr.) | 14.40 | 8.75 | 11.07 | 18.02 | 6.92 | 3.33 |
| Calculated EPS (Unit Curr.) | 14.39 | 8.74 | 11.06 | 18.01 | 6.93 | 3.33 |
| Calculated EPS (Adj) (Unit Curr.) | 14.39 | 8.74 | 11.06 | 18.01 | 6.93 | 3.33 |
| Calculated EPS (Ann.) (Unit Curr.) | 57.56 | 34.97 | 44.25 | 72.04 | 27.70 | 13.31 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 57.56 | 34.97 | 44.25 | 72.04 | 27.70 | 13.31 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 13.37 | 13.37 | 13.37 | 13.37 | 13.37 | 13.37 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 16.36 | 15.06 | 15.11 | 20.03 | 12.35 | 14.96 |
| PBDTM(%) | 16.36 | 15.06 | 15.11 | 20.03 | 12.35 | 14.96 |
| PATM(%) | 9.99 | 8.52 | 7.62 | 13.96 | 5.46 | 4.20 |